Skip to main content

Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

BMC Cancer

ISSN: 1471-2407

Contact us